Literature DB >> 2842799

Lysogeny and transformation in mycobacteria: stable expression of foreign genes.

S B Snapper1, L Lugosi, A Jekkel, R E Melton, T Kieser, B R Bloom, W R Jacobs.   

Abstract

Requisite to a detailed understanding of the molecular basis of bacterial pathogenesis is a genetic system that allows for the transfer, mutation, and expression of specific genes. Because of the continuing importance of tuberculosis and leprosy worldwide, we initiated studies to develop a genetic system in mycobacteria and here report the use of two complementary strategies to introduce and express selectable genetic markers. First, an Escherichia coli cosmid was inserted into the temperate mycobacteriophage L1, generating shuttle phasmids replicating as plasmids in E. coli and phage capable of lysogenizing the mycobacterial host. These temperate shuttle phasmids form turbid plaques on Mycobacterium smegmatis and, upon lysogenization, confer resistance to superinfection and integrate within the mycobacterial chromosome. When an L1 shuttle phasmid containing a cloned gene conferring kanamycin resistance in E. coli was introduced into M. smegmatis, stable kanamycin-resistant colonies--i.e., lysogens--were obtained. Second, to develop a plasmid transformation system in mycobacteria, M. fortuitum/E. coli hybrid plasmids containing mycobacterial and E. coli replicons and a kanamycin-resistance gene were constructed. When introduced into M. smegmatis or BCG (Mycobacterium tuberculosis typus bovinus var. Bacille-Calmette-Guérin) by electroporation, these shuttle plasmids conferred stable kanamycin resistance upon transformants. These systems should facilitate genetic analyses of mycobacterial pathogenesis and the development of recombinant mycobacterial vaccines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842799      PMCID: PMC282104          DOI: 10.1073/pnas.85.18.6987

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Bacteriophage active against virulent Mycobacterium tuberculosis. I. Isolation and activity.

Authors:  S FROMAN; D W WILL; E BOGEN
Journal:  Am J Public Health Nations Health       Date:  1954-10

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  Report on a pseudolysogenic mycobacterium and a review of the literature concerning pseudolysogeny.

Authors:  I Baess
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  Nucleotide sequence of the kanamycin resistance transposon Tn903.

Authors:  A Oka; H Sugisaki; M Takanami
Journal:  J Mol Biol       Date:  1981-04-05       Impact factor: 5.469

6.  A small cosmid for efficient cloning of large DNA fragments.

Authors:  B Hohn; J Collins
Journal:  Gene       Date:  1980-11       Impact factor: 3.688

7.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies.

Authors:  P G Smith; L C Rodrigues; P E Fine
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

8.  The Kellersberger memorial lecture, 1985. The role of BCG in the control of leprosy.

Authors:  P E Fine
Journal:  Ethiop Med J       Date:  1985-10

9.  Functional expression of two Bacillus subtilis chromosomal genes in Escherichia coli.

Authors:  N Y Chi; S D Ehrlich; J Lederberg
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490

10.  Selective primary health care: strategies for control of disease in the developing world. V. Leprosy.

Authors:  B R Bloom; T Godal
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug
View more
  91 in total

1.  Assembly and activation of site-specific recombination complexes.

Authors:  C E Peña; J M Kahlenberg; G F Hatfull
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Method to integrate multiple plasmids into the mycobacterial chromosome.

Authors:  Beatrice Saviola; William R Bishai
Journal:  Nucleic Acids Res       Date:  2004-01-12       Impact factor: 16.971

3.  Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli.

Authors:  A Baulard; C Jourdan; A Mercenier; C Locht
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Phage L5 integrating vectors are present within the Mycobacterial Cell in an equilibrium between integrated and excised states.

Authors:  Beatrice Saviola
Journal:  Cancer Ther       Date:  2009-01

Review 5.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

6.  The cohesive ends of mycobacteriophage L5 DNA.

Authors:  M Oyaski; G F Hatfull
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Establishment of a foreign antigen secretion system in mycobacteria.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; M Totsuka; K Kobayashi; H Yukitake; T Yamada
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

8.  Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes.

Authors:  M A O'Donnell; A Aldovini; R B Duda; H Yang; A Szilvasi; R A Young; W C DeWolf
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Gene replacement through homologous recombination in Mycobacterium intracellulare.

Authors:  B I Marklund; D P Speert; R W Stokes
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

10.  cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase.

Authors:  C Shoemaker; A Gross; A Gebremichael; D Harn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.